<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ENZ</title>
    <link />
    <description>Headlines for Enzo Biochem, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Interesting ENZ Call For January 2014</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928234/1/interesting-enz-call-for-january-2014.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 12:43:00 GMT</pubDate>
    </item>
    <item>
      <title>Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for Autoimmune Diseases</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/enzo-and-nih-file-patent-application-for-therapies/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 09:06:26 GMT</pubDate>
    </item>
    <item>
      <title>The Market Likes Sangamo's Search For An HIV/AIDS Cure</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1298561-the-market-likes-sangamo-s-search-for-an-hiv-aids-cure.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 25 Mar 2013 11:19:11 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Investors Have To Be In It For The Long Haul</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1287391-enzo-investors-have-to-be-in-it-for-the-long-haul.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Mar 2013 16:52:40 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Management Discusses Q2 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1269771-enzo-biochem-management-discusses-q2-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Mar 2013 11:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Reports Fiscal Second Quarter Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/12/enzo-biochem-reports-fiscal-second-quarter-results/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 12 Mar 2013 16:50:14 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Schedules Teleconference to Discuss Second Quarter Results on March 13, 2013 at 8:30 AM</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/08/enzo-biochem-schedules-teleconference-to-discuss-s/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 08 Mar 2013 14:05:23 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Reports First Quarter Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/10/enzo-biochem-reports-first-quarter-results/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 10 Dec 2012 17:05:21 GMT</pubDate>
    </item>
    <item>
      <title>Pre-Market Earnings Report for December 11, 2012 :  DG, PTRY, ENZ, HSOL</title>
      <link>http://www.fool.com/news/xt/nasdaq/community.nasdaq.com/news/2012-12/premarket-earnings-report-for-december-11-2012-dg-ptry-enz-hsol.aspx.aspx?storyid=197567</link>
      <author>Nasdaq</author>
      <pubDate>Mon, 10 Dec 2012 16:00:03 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Schedules Teleconference to Discuss First Quarter Results on December 11, 2012 at 8:30</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/06/enzo-biochem-schedules-teleconference-to-discuss-f/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 06 Dec 2012 11:20:50 GMT</pubDate>
    </item>
    <item>
      <title>4 Big Volume Gainers Under $10</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-big-volume-gainers-under-10.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Tue, 13 Nov 2012 18:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem’s Clinical Labs Introduces Diagnostic Test That Assists in Early Detection of Lung Canc</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/13/enzo-biochems-clinical-labs-introduces-diagnostic-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 13 Nov 2012 07:42:54 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem to Present at Lazard Capital Markets 9th Annual Healthcare Conference</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/12/enzo-biochem-to-present-at-lazard-capital-markets-/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 12 Nov 2012 11:50:32 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Reports Jury Declares Life Technologies Infringed Company Patents and Awards Enzo $48.6</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/02/enzo-biochem-reports-jury-declares-life-technologi/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 02 Nov 2012 09:21:24 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Reports Fourth Quarter Results and Announces Realignment Program Expected to Reduce Ann</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/10/15/enzo-biochem-reports-fourth-quarter-results-and-an/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 15 Oct 2012 16:27:14 GMT</pubDate>
    </item>
    <item>
      <title>Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter Results on October 16, 2012 at 8:30</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/10/12/enzo-biochem-schedules-teleconference-to-discuss-f/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 12 Oct 2012 15:35:16 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks Poised for Breakouts</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-18.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 21 Sep 2012 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Upgrades: Hospital Stocks Nursed Back to Health</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/upgrades-downgrades-initiations-stock-market-analyst/6/11/2012/id/41628.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 11 Jun 2012 09:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Downgrades: No Sugar High for Nestle</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/upgrades-downgrades-initiations-stock-market-analyst/6/11/2012/id/41629.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 11 Jun 2012 09:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Labcorp's Acquisition Of Medtox Leaves Enzo As An Attractive Investment Opportunity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/646861-labcorp-s-acquisition-of-medtox-leaves-enzo-as-an-attractive-investment-opportunity.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 08 Jun 2012 10:18:36 GMT</pubDate>
    </item>
  </channel>
</rss>
